Novartis backs full year forecast after $6 billion profit beat helped by one-offs
By Bhanvi Satija and Marleen Kaesebier LONDON, July 21 - Novartis beat second-quarter profit forecasts and kept its 2026 outlook unchanged on Tuesday, saying one-off benefits that helped the quarter would reverse as it increases research and launch spending in the second half. 
